IL1B and systemic sclerosis: A reduced production of IL-1RII may not be able to confer significant protection to the cells from the autocrine and paracrine effects of IL-1, thus, exposing them to an increased risk related to the oxidative stress induced by NO, a key phenomenon in the pathogenesis of SSc.